MD Anderson Oncologist Stephen Hahn Is Trump’s First Choice For FDA Commissioner: Reports

Media reports say President Trump will nominate Stephen Hahn, an oncologist serving as chief medical executive of MD Anderson Cancer Center, as the next US FDA commissioner. This comes despite a group of former agency chiefs’ support for the current acting commissioner, Ned Sharpless, to permanently fill the spot.

Stephen Hahn, chief medical executive, MD Anderson Cancer Center.

More from Leadership

More from Medtech Insight